Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134856) titled 'Efficacy and Safety of Nebulized Inhalation Therapy in GOLD Group B Patients with Chronic Obstructive Pulmonary Disease: A Real-World Study' on Oct. 21.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Meishan City Peoples Hospital
Condition:
Clinically diagnosed COPD in GOLD Group B
Intervention:
Observation group 1 (COPD - LAMA/LABA dual bronchodilator therapy):None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-31
Target Sample Size: Observation group 1 (COPD - LAMA/LABA dual bronchodilator therapy):207;Observation group 2 (COPD - ICS/LAMA/...